Scancell to produce and clinically validate T cell redirecting bispecific antibodies To download click here Thursday 23 June 2022 10:38 Categories: GlyMab News Regulatory News Year - 2022
Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded To download click here Wednesday 15 June 2022 11:03 Categories: News Regulatory News SCIB1 Year - 2022
First patient dosed in Modi-1 Phase 1 clinical trial To download click here Monday 13 June 2022 14:16 Categories: Modi-1 Moditope News Regulatory News Year - 2022
Modi-1 Phase 1/2 clinical trial open for recruitment To download click here Wednesday 13 April 2022 11:16 Categories: Modi-1 News Regulatory News Year - 2022
Broadening of COVIDITY Phase 1 clinical trial in South Africa To download click here Tuesday 29 March 2022 08:18 Categories: Covid-19 News Regulatory News Year - 2022
Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™ To download click here Thursday 17 March 2022 17:08 Categories: GlyMab Year - 2022
Update on COVIDITY Phase 1 clinical trial in South Africa To download click here Monday 31 January 2022 14:16 Categories: Covid-19 News Regulatory News Year - 2022
Interim Results for the 6 months ended 31 October 2021 To download click here Wednesday 26 January 2022 08:57 Categories: News Regulatory News Year - 2022
Results of AGM 2021 To download click here Wednesday 24 November 2021 13:43 Categories: News Regulatory News
Introducing Scancell's New Facilities Wednesday 24 November 2021 13:01 Categories: Media Coverage News Year - 2021